Table 4 Stratified association between muscle mass adjusted by BMI and 30-day mortality by sex, age, APACHE score, and SOFA score.

From: The effects of muscle mass and quality on mortality of patients with acute kidney injury requiring continuous renal replacement therapy

 

N

SMA/BMI

NAMA/BMI

LAMA/BMI

Sex

 Male

1318

0.77 (0.61,0.96)

1.03 (0.83,1.29)

0.73 (0.61,0.88)

 Female

882

0.95 (0.61,1.46)

1.33 (0.79,2.23)

0.79 (0.56,1.10)

 Age

 < 65

933

1.01 (0.72,1.41)

0.98 (0.72,1.34)

1.04 (0.78,1.37)

 ≥ 65

1267

0.71 (0.55,0.91)

1.14 (0.87,1.49)

0.64 (0.52,0.78)

APACHE II

 < Median

879

0.82 (0.54,1.26)

1.04 (0.67,1.61)

0.76 (0.53,1.10)

 ≥ Median

1008

0.88 (0.63,1.23)

1.23 (0.89,1.72)

0.70 (0.53,0.92)

SOFA

 < Median

602

0.89 (0.47,1.69)

1.35 (0.71,2.57)

0.59 (0.32,1.08)

 ≥ Median

704

0.93 (0.61,1.43)

1.28 (0.88,1.87)

0.69 (0.48,0.97)

AKI cause

 Sepsis

905

0.72 (0.47,1.10)

1.16 (0.75,1.78)

0.56 (0.38,0.82)

 Non-sepsis

1295

0.90 (0.67,1.21)

1.27 (0.95,1.71)

0.67 (0.52,0.87)

Hypertension

 No

1362

0.86 (0.69,1.07)

1.21 (0.97,1.51)

0.70 (0.59,0.84)

 Yes

838

0.75 (0.49,1.14)

0.91 (0.58,1.40)

0.84 (0.62,1.14)

Diabetes

 No

1412

0.77 (0.58,1.03)

1.00 (0.76,1.31)

0.80 (0.65,0.98)

 Yes

788

0.56 (0.30,1.04)

0.61 (0.30,1.24)

0.77 (0.48,1.24)

  1. SMA skeletal muscle mass; NAMA normal attenuation muscle area; LAMA low attenuation muscle area; BMI body mass index; APACHE II Acute Physiology and Chronic Health Evaluation; SOFA sequential organ failure assessment; AKI, acute kidney injury.